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EpsC, one of the components comprising the type II secretion system (T2SS), was isolated from a human-
pathogenic bacterium, Vibrio vulnificus, to evaluate its role in eliciting virulence. An espC-deleted mutant of V.
vulnificus displayed a reduced cytotoxicity to the human cell line HEp-2 and an attenuated virulence in a mouse
model. This mutant exhibited dramatic defects in the secretion of diverse extracellular proteins, such as outer
membrane proteins, transporters, and the known secreted factors, notably, a hemolysin (VvhA) and an elastase
(VvpE). A defect in its secretion of proteins was restored by in trans complementation of the intact epsC gene.
Analyses of cellular fractions revealed that VvhA and VvpE of the epsC mutant were not excreted outside the
cell but were present mainly in the periplasmic space. Examination of a V. vulnificus mutant deficient in TolC,
a component of the T1SS, showed that it is not involved in the secretion of VvhA and VvpE but that it is
necessary for the secretion of another major toxin of V. vulnificus, RtxA. Therefore, the T2SS is required for V.
vulnificus pathogenicity, which is mediated by at least two secreted factors, VvhA and VvpE, via facilitating the
secretion and exposure of these factors to host cells.
Seven distinct pathways for the secretion of extracellular
proteins have been identified in Gram-negative bacteria to
date (1, 40). These include the signal sequence-independent
pathway (type I), the main terminal branch of the general
secretion pathway (type II), the contact-dependent pathways
(type III and type IV), the filamentous hemagglutinin secretion
pathway, and the autotransporter pathway. For many patho-
gens, the type II secretion system (T2SS) is involved in the
secretion of diverse virulence factors, including proteases (38),
lipases (32, 44), cellulases (39), pectinases (3), phospholipases
(58), and toxins (18, 46, 56). Secretion via the T2SS occurs in
two distinct steps. First, the proteins to be secreted are ex-
pressed with signal peptides that target them to either the Sec
or Tat machinery for transport across the cytoplasmic mem-
brane into the periplasm (14). Once the signal peptides of the
target proteins are removed, the processed proteins are trans-
located across the outer membrane.
In Vibrio cholerae, the T2SS apparatus is encoded by at least
12 genes, including a cluster of genes encompassing the epsC
gene to the epsN gene and a separate locus encoding PilD (14).
Inactivation or removal of the T2SS machinery in V. cholerae
results in a defect in the extracellular release of its periplasmic
content and an increased sensitivity to bile salt and polymyxin
B (53). The structures of some components of the T2SS, i.e.,
EpsM, EpsE, and EpsC, of V. cholerae have been characterized
(2, 15, 24, 42). EpsC protein is one of the key components
connecting the inner and outer membrane secretion system,
and its role in the secretion system has been experimentally
verified in V. cholerae (24).
Vibrio vulnificus is a Gram-negative pathogenic bacterium
that is frequently associated with primary septicemia following
consumption of contaminated shellfish (12, 16). Among se-
creted proteins from V. vulnificus, a cytolytic hemolysin
(VvhA) (61), an elastase (VvpE) (35), and a contact-depen-
dent killing toxin (RtxA) (22, 28) have been proven to directly
cause severe damage to human tissues. The role of the T2SS in
the pathogenesis of V. vulnificus has been implied by evaluat-
ing the phenotype of a mutant with a knockout of the pilD
gene, coding for the type IV leader peptidase/N-methyltrans-
ferase, which is also involved in the biogenesis of type IV pili
(37, 38). Thus, the pilD mutant was not only defective in the
extracellular activities of some proteins but also unable to form
type IV pili, which are important for the pathogenesis of V.
vulnificus (36, 37). It suggests that the reduced virulence of the
pilD mutant might be caused by both a defect in the T2SS and
a defect of pilus formation. In addition, RtxA secretion has not
been thoroughly examined in V. vulnificus to determine
whether it is mediated by the T2SS and/or the type I secretion
system (T1SS) (29), although V. cholerae RtxA was reported to
be secreted by the T1SS (6). Therefore, we investigated the
roles of the T2SS in V. vulnificus without affecting the forma-
tion of type IV pili by constructing a mutant with the epsC
gene, encoding an essential structural component of the T2SS,
knocked out and by comparing its phenotypes with those of the
T1SS mutant of V. vulnificus.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains and plasmids
used in this study are listed in Table 1. Escherichia coli strains used for plasmid
DNA preparation and the conjugational transfer of plasmids were grown at 37°C
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in Luria-Bertani (LB) broth or on LB broth containing 1.5% agar. V. vulnificus
strains were cultured at 30°C in LB medium supplemented with an additional 2%
NaCl (LBS). The V. vulnificus rtxA mutant was a gift from S. H. Choi (Seoul
National University) (28).
The following antibiotics were used at the indicated concentrations: ampicillin
(100 g/ml), chloramphenicol (25 g/ml), kanamycin (50 g/ml), and tetracy-
cline (10 g/ml) for E. coli and ampicillin (500 g/ml), chloramphenicol (2
g/ml), kanamycin (100 g/ml), and tetracycline (3 g/ml) for V. vulnificus. All
medium components were purchased from Difco, and the chemicals and antibi-
otics were obtained from Sigma.
Construction of the mutant strains of V. vulnificus. For construction of the
epsC mutant, the upstream region of the epsC gene was amplified from the
genomic DNA of V. vulnificus MO6-24/O with the primers epsCupF and
epsCupR (Table 2). The resultant 520-bp DNA fragment was then digested with
ApaI and PstI and ligated into pBlueScript (II) SK (), to produce pSKepsCup.
The downstream region of the epsC gene was amplified using the primers
epsCdownF and epsCdownR (Table 2). The resultant DNA fragment of 506 bp was
treated with PstI and SacI and ligated into pSKepsCup to yield pSKepsCupdown.
The 1,026-bp ApaI-SacI DNA fragment of pSKepsCupdown was transferred into
a suicide vector, pDM4 (33), resulting in the formation of pDMepsC. The
plasmid pDMepsC in SM10 pir (54) was mobilized to V. vulnificus MO6-24/O,
and the conjugants were selected by plating the conjugation mixture of E. coli
and V. vulnificus on LBS plates supplemented with 2 g/ml chloramphenicol. A
colony with characteristics indicating a double-homologous-recombination event
(resistance to 5% sucrose and sensitivity to chloramphenicol) was further con-
firmed by PCR using the primers epsCupF and epsCdownR and then named
HW1. For complementation of the mutant, a 1,035-bp DNA fragment was
amplified using epsCcomF and epsCcomR (Table 2), which contains an epsC
open reading frame (ORF) and a 136-bp region upstream of the epsC gene. This
DNA fragment was then cloned into the broad-host-range vector pRK415 (19) to
produce pRKepsC. This epsC-containing plasmid was mobilized to the epsC
strain via conjugation. The wild type carrying pRK415 and the epsC strain
carrying pRK415 were also constructed in the same manner to serve as controls.
For construction of the vvhA mutant, the upstream (1,037-bp) and downstream
(469-bp) regions of the vvhA gene were amplified using the primer sets vvhAupF/
vvhAupR and vvhAdownF/vvhAdownR, respectively (Table 2). The ApaI-SacI
DNA fragment of pSKvvhAupdown was transferred into pDM4 to produce
pDMvvhA, which was then used to generate a V. vulnificus vvhA mutant, as
described above. Similarly, a plasmid (pMLE02) including the upstream (798-bp)
and downstream (1,031-bp) regions of the vvpE gene were amplified by the
following primer sets: vvpE-upF/vvpE-upR and vvpE-downF/vvpE-downR (Ta-
ble 2). A gene, nptI, encoding a kanamycin resistance enzyme isolated from
pUC4K (Pharmacia), was inserted into pMLE02 to generate pMLE03. The
ApaI-XbaI DNA fragment of pMLE03 was ligated into pDM4 to produce
pMLE04, which was used to make the V. vulnificus vvpE mutant, as described
above. To inactivate the tolC gene, the primer sets of tolCupF/tolCupR and
tolCdownF/tolCdownR (Table 2) were utilized to produce the 530-bp upstream
and the 545-bp downstream regions of tolC gene. A 1,075-bp DNA fragment of
pSKtolCupdown was cloned into pDM4 to make pDMtolC, which was used to
generate the V. vulnificus tolC mutant. A V. vulnificus strain defective in both
the rtxA and epsC genes were constructed by allelic exchange via a conjugal
transfer of pDMepsC into the V. vulnificus rtxA mutant (28).
Preparation of polyclonal of antibodies. The 795-bp DNA encompassing the
epsC ORF was amplified using two primers, repsCF and repsCR (Table 2), and
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristic(s) Source or reference
E. coli
DH5 supE44 lacU169 (80 lacZM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Laboratory collection
SM10 pir thi thr leu tonA lacY supE recA::RP4-2-Tc::Mu pir, OriT of RP4, Kmr, conjugational donor 54
BL21(DE3) E. coli B F dcm ompT hsdS (rB
 mB
) gal  (DE3) Invitrogen
V. vulnificus
MO6-24/O Clinical isolate 61
HW1 epsC mutant of MO6-24/O This study
HW2 vvhA mutant of MO6-24/O This study
ML06 vvpE mutant of MO6-24/O This study
HW4 epsC rtxA mutant of MO6-24/O This study
HW3 tolC mutant of MO6-24/O This study
MW064 rtxA mutant of MO6-24/O 28
Plasmids
pBluescript (II) SK () Cloning vector, Apr, lac promoter (lacZ), f1 ColE1 Stratagene
pSKepsCup pBluescript (II) SK (), 520 bp upstream of epsC This study
pSKepsCupdown pSKepsCup, 506 bp downstream of epsC This study
pSKvvhAup pBluescript (II) SK (), 1,037 bp upstream of vvhA This study
pSKvvhAupdown pSKvvhAup, 469 bp downstream of vvhA This study
pMLE01 pBluescript (II) SK (), 798 bp upstream of vvpE This study
pMLE02 pMLE01, 1,031 bp downstream of vvpE This study
pMLE03 pMLE02, 1,258-bp nptI gene, Kanr This study
pUC4K pUC4 with nptI, Apr Kmr Pharmacia Biotech
pSKtolCup pBluescript (II) SK (), 530 bp upstream of tolC This study
pSKtolCupdown pSKtolCup, 545 bp downstream of tolC This study
pDM4 Suicide vector, OriR6K Cmr 33
pDMepsC pDM4, 1,026-bp epsC DNA fragment This study
pDMvvhA pDM4, 1,506-bp vvhA DNA fragment This study
pMLE04 pDM4, 3,087-bp vvpE-nptI DNA fragment This study
pDMtolC pDM4, 1,075-bp tolC DNA fragment This study
pRK415 Broad-host-range plasmid, Tcr 19
pRKepsC pRK415, 1,035-bp epsC This study
pET21b () Expression vector for a histidine-tagged protein Novagen
pETrepsC pET21b (), 776-bp epsC This study
pETrvvpE pET21b (), 1,826-bp vvpE This study
pET28b () Expression vector for a histidine-tagged protein Novagen
pETrvvhA pET28b (), 1,411-bp vvhA This study
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then cloned into the pET21b () expression vector (Novagen). The recombinant
EpsC (rEpsC) protein was overexpressed by adding isopropyl--D-thiogalacto-
side (IPTG) at a concentration of 1 mM and then separated by 12% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The induced
protein band was excised, resuspended with phosphate-buffered saline (PBS; 137
mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 2 mM KH2PO4, pH 7.4). This
protein was confirmed to be V. vulnificus EpsC by matrix-assisted laser desorp-
tion ionization-time of flight mass spectrometry (MALDI-TOF MS) analysis as
described below, and then it was used as an antigen to produce polyclonal
antibodies (Ab) via intraperitoneal injection into pathogen-free rats (CrjBgi; CD
[SD] IGS, 6-week-old female rats). After three injections at 2-week intervals,
sera were obtained from the immunized rats, and the titer of the resultant Ab was
tested. The vvhA DNA fragment of 1,411 bp was cloned into the pET28b ()
expression vector to produce pETrvvhA. The rVvhA protein was used as an
antigen to prepare Ab specific to the V. vulnificus VvhA protein by immunization
of rats as described above. A vvpE-containing DNA fragment of 1,826 kb was
also amplified by PCR using the primers rvvpEF and rvvpER (Table 2) and then
cloned into pET21b () to produce pETrvvpE. The recombinant protein was
overexpressed in E. coli BL21 cells harboring the expression plasmid with 1 mM
IPTG and separated by 12% SDS-PAGE to immunize a pathogen-free rat. The
identities of all the recombinant proteins used for immunization were confirmed
by in-gel digestion with trypsin (Sigma) and subsequent MS analyses. MS ana-
lyses were performed using a MALDI-TOF Voyager DETM STR biospectrom-
etry workstation (Applied Biosystems). The resultant trypsin peptide profiles
were used to search the Swiss-Prot protein (www.expasy.ch) and NCBI (www
.ncbi.nlm.nih.gov) databases, primarily with the MASCOT (Matrix Science)
search engine.
Western blot analyses. Bacterial extracts were prepared by sonication of bac-
terial cells in TNT buffer (10 mM Tris-HCl [pH 8.0], 150 mM NaCl, and 0.05%
[vol/vol] Tween 20). The protein pool in the culture supernatants was concen-
trated 200-fold by precipitation with trichloroacetic acid (TCA) or filtration
through Amicon/Centricon YM-10 columns (Millipore). Cell lysates and con-
centrated supernatants prepared in sample buffer (50 mM Tris-HCl, pH 6.8, 100
mM dithiothreitol, 2% SDS, 0.1% bromophenol blue, and 20% glycerol) were
separated by SDS-PAGE and transferred onto nitrocellulose membranes (Mil-
lipore). Membranes were blocked with 3% skim milk in Tris-buffered saline with
Tween 20 (TBST; 150 mM NaCl, 50 mM Tris-HCl, and 0.1% Tween 20) and then
incubated overnight at 4°C with the polyclonal Ab (1:2,000 dilution). After
incubation with alkaline phosphate (AP)-conjugated secondary Ab, immunore-
active bands were visualized using nitro blue tetrazolium and 5-bromo-4-chloro-
3-indolyl phosphate. For analysis of RtxA, a contact-dependent exoprotein, V.
vulnificus strains were incubated with HEp-2 cells for 2 h at a multiplicity of
infection (MOI) of 20, as previously described (22, 28, 29). The resultant secre-
tomes were concentrated by using Amicon/Centricon YM-10 columns (Milli-
pore) and analyzed by Western blotting using anti-RtxA Ab (1:2,000 dilution),
which was a gift from S. H. Choi.
Secretome analyses. The wild-type and epsC mutant strains were cultured to
the exponential phase (optical density at 600 nm [OD600] 	 0.8) or the stationary
phase (OD600 	 4.0), and their culture supernatants were then collected by
passing cells through 0.22-m-pore-size filters. Filtered supernatants were mixed
with the same volume of prechilled 10% TCA and incubated on ice for 30 min.
After a 30-min centrifugation at 9,000 rpm and 4°C, the pellets were washed with
acetone three times, dried, and then resuspended in lysis buffer (50 mM
NaH2PO4, 300 mM NaCl, and 10 mM imidazole, pH 8.0). The protein contents
in the secretome preparations were determined by a Bio-Rad protein assay kit
(Bio-Rad). One hundred nanograms or 50 g of proteins was separated by
5-to-20% gradient SDS-PAGE and visualized by silver nitrate or Coomassie blue
staining, respectively. Protein bands showing differential intensity between the
wild-type and epsC strains were excised and treated by in-gel digestion with
trypsin (Sigma). MS analyses of these trypsin-treated proteins were performed as
described above. Some proteins presented in Table 2 were further analyzed by
quadrupole TOF (Q-TOF) in addition to MALDI-TOF MS. Product ion spectra
were collected in the information-dependent acquisition (IDA) mode and were
analyzed with an Agilent 6530 accurate-mass Q-TOF MS. For the Q-TOF liquid
chromatography-tandem MS (LC-MS/MS) data sets, tandem mass spectra were
submitted to our MASCOT in-house database search engine (NCBI NR data-
base downloaded on 31 July 2009). Mass tolerances of 100 ppm and 0.2 Da were
used for precursor and fragment ions, respectively. For protein identification, a
MASCOT ion score of 
26 was used as the criterion.
Cytotoxicity assay. HEp-2 cells were seeded at 2  105 cells per well into
12-well culture plates and grown overnight at 37°C in the presence of 5% CO2.
V. vulnificus cells harvested at an OD600 of 0.8 or 4.0 were added to HEp-2 cells
at an MOI of 20 and then incubated at 37°C for an additional hour in the
presence of 5% CO2. Otherwise, HEp-2 cells (2  105) were treated with the
concentrated proteins in the culture supernatants (4 or 8 g protein/ml), fol-
lowed by 4 h of incubation at 37°C. The cells were detached from the culture
plates by a 10-min treatment with 0.025% trypsin-0.02% EDTA solution and
stained with propidium iodide (PI; BD Pharmingen) at a final concentration of
1 g/ml. The degree of cell death was assessed using fluorescence-activated cell
sorting (FACS) analysis of PI-stained cells. At least 10,000 events were collected
per sample with a FACScan (Becton Dickinson).
TABLE 2. Oligonucleotide primers used in this study
Primer Nucleotide sequence (5–3)a Enzyme site
epsCupF GATCGGGCCCTGCACGTTGGCCATTATAGTGGACT ApaI
epsCupR GATCCTGCAGAATCATCCGCGTCAGCAATGGGCTA PstI
epsCdownF GATCCTGCAGTAACACTTAGGCTCAAAGCGTAAG PstI
epsCdownR GATCGAGCTCCACGTTACCAGCGCCCGCATTATCAATC SacI
epsCcomF GATCCTGCAGTCGAATAAAGAAAGATAAATC PstI
epsCcomR GATCGAATTCACGCTTTGAGCCTAAGTGTTA EcoRI
vvhAupF ATCGGGGCCCATTTCGATTTTTCATTGAATAAA ApaI
vvhAupR CAGCGGATCCCATCTTATTTTCCCTCAGATT BamHI
vvhAdownF CAGCGGATCCGTCGGTGGTCGTATGTT BamHI
vvhAdownR ATCGGAGCTCGGTAATCAGGAACTCATTTCG SacI
vvpE-upF CCGCTCGAGGGAGAGAGTCATGTACAGTGAGG PstI
vvpE-upR CGGGATCCGCAAACCGACCACAAGTTCTTGG BamHI
vvpE-downF CGGGATCCCGAGACTACGAGCTTGAACGGA BamHI
vvpE-downR GCTCTAGACCATCACTTGAAGACCAAAGGC XbaI
tolCupF ATGCGGGCCCTTAAACAATTCATTTATTGCACAACTG ApaI
tolCupR ATGCCTGCAGGATCAAACCCTGTTGCGTCGCTGCGTAT PstI
tolCdownF GATCCTGCAGGTTGATGCTGGTTTGATTGCGAA PstI
tolCdownR GATCGAGCTCTGGCTGCTTCGACATCCTTCATGC SacI
repsCF GATCCATATGACAGGCTGGACTTTAGGGCAAGTC NdeI
repsCR GATCCTCGAGGTAAATATCATGCTGCTGTCCGT XhoI
rvvhAF GATCCCATGGAGATGAAAAAAATGACTCTGTTTACC NcoI
rvvhAR GAGCCTCGAGTTTGACTTGTTGTAATGTGG XhoI
rvvpEF GATCCATATGAAACACAACCAACGTCATCGT NdeI
rvvpER GATCCTCGAGCTTTAACGTCACACCGTTGTA XhoI
a The indicated restriction site is underlined.
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Virulence in mice. At an OD600 of 0.8, bacterial cells were harvested and
washed twice with PBS. Equal numbers (6  105) of bacteria were intraperito-
neally injected into specific-pathogen-free, 7-week-old, female ICR mice (10
mice per group; Orient Bio Inc.), and the number of live mice was monitored for
25 h after the injection.
Estimation of hemolytic activity. Bacterial growth was monitored by measur-
ing the OD600 of cultures, and the supernatants of cultures were prepared by
centrifugation and filtration. Serial 2-fold dilutions of culture supernatants in
PBS including bovine serum albumin (1 mg/ml) were incubated with equal
volumes of PBS containing 1% human red blood cells (RBCs) at 37°C for 1 h.
After unlysed RBCs were removed by centrifugation, the lysed RBCs were
quantitatively measured by determining spectrometry at an OD540. Hemolysin
activity was expressed as (OD540 of sample)/(OD540 of hemolysis induced by
0.02% Triton X-100) (4, 51).
Detection and quantification of exoprotease activity. For detection of the
exoprotease activities of bacterial cells, bacterial cells or culture supernatants
harvested at various time points were used to assay proteolytic activity as de-
scribed previously (11, 43, 59). Briefly, filtered supernatants were incubated at
30°C for 1 h with equal volumes of azocasein solution (5 mg/ml in 50 mM
Tris-HCl, pH 8.0, and 0.04% NaN3). Upon the termination of the reactions with
the addition of 6.7% (wt/vol) TCA and subsequent centrifugation (12,000 rpm, 4
min) to remove unreacted azocasein, the absorbance of the supernatant contain-
ing azopeptides was measured at 442 nm. To visualize the proteolytic band
derived from elastase activity in a polyacrylamide gel, a zymographic analysis was
performed as described previously (43).
Fractionation of bacterial cells and measurement of alkaline phosphatase
activity. Various V. vulnificus strains, the wild-type, epsC, and vvhA strains,
were freshly grown to an OD600 of 1 at 30°C in LBS broth. Through centrifu-
gation, the culture supernatant was separated from the bacterial cells. The
harvested cells were then divided into cytoplasmic and periplasmic fractions as
described by Manoil and Beckwith (31). Harvested cells were resuspended in a
spheroplast buffer (100 mM Tris-HCl, pH 8.0, 0.5 mM EDTA, 0.5 mM sucrose,
1 mM MgCl2, and 20 g/ml phenylmethylsulfonyl fluoride [PMSF]) and sub-
jected to centrifugation (3 min, 13,000 rpm, 4°C). The pellets were warmed,
resuspended in ice-cold water, and treated with 20 mM MgCl2. Then, osmotically
shocked cells were centrifuged (5 min, 13,000 rpm, 4°C), the supernatants were
saved as periplasmic fractions, and the pellets were further resuspended in a
solution containing 10 mM Tris-HCl, pH 8.0, and 20 g/ml PMSF. The cells in
the pellet fractions were lysed by a treatment with lysozyme (20 g/ml) and a
series of freezing/thawing. After centrifugation, the resultant supernatants were
saved as cytoplasmic fractions.
Three fractions, i.e., a culture supernatant, a periplasmic fraction, and a
cytoplasmic extract, were assayed for their alkaline phosphatase activity in a
reaction mixture (50 mM Tris-HCl, pH 8.0, and 1 mM MgCl2) including 0.2
mg/ml p-nitrophenylphosphate as described previously (53, 62). After incubation
at 37°C for 40 min, the reactions were terminated by adding 50 mM EDTA and
monitored for their absorbance at 405 nm. Specific activity was defined by the
formula (OD420/reaction time [in minutes]  milligrams of protein)  1,000.
Statistical analyses. Results are expressed as the averages  standard devia-
tions of results from at least three independent experiments. Statistical analysis
was performed using analysis of variance (ANOVA). Differences were judged as
statistically significant when the P value was less than 0.05. Statistical analysis for
pairwise comparison was performed using Student’s t test (SYSTAT program,
SigmaPlot version 9; Systat Software Inc.). Differences were considered signifi-
cant if the P values were 0.05. A log rank test (http://bioinf.wehi.edu.au
/software/russell/logrank/) was performed to estimate the statistical significance
of the mouse lethality experiments.
RESULTS
In silico analysis of the T2SS in V. vulnificus. Using the
amino acid sequences for T2SS members of V. cholerae, the V.
vulnificus CMCP6 genomic database (GenBank accession no.
AE016795 and AE016796) was screened for the putative T2SS
components. Genes for proteins EpsC to -N (from VV1_0878
to VV1_0867) were clustered in chromosome 1 of V. vulnificus.
The pilD gene for type IV leader peptidase/N-methyltrans-
ferase, which is involved in both the T2SS and type IV pilus
biogenesis in V. vulnificus, was located at a separate locus
(VV1_1623). An epsA-homologous ORF (VV1_0621) with
50% similarity to the V. cholerae EpsA protein was found at a
site distal from the eps cluster. We could not identify any gene
homologous to epsB in the V. vulnificus genome. Each compo-
nent of the T2SS in the other Vibrio spp. (V. parahaemolyticus,
V. cholerae, V. harveyi, and V. fischeri) showed homology with
that of V. vulnificus, ranging from 61 to 96%, and no distinct
difference was observed in the degrees of homology in Eps
proteins among pathogenic and nonpathogenic vibrios.
In V. cholerae, EpsE, EpsL, EpsM, and EpsA comprise the
secretion machinery in the inner membrane, and EpsD is a
member of a secretory apparatus in the outer membrane (14,
47, 53). As a component connecting the inner and outer mem-
brane secretion apparatus, EpsC has been shown to be crucial
for successful secretion in V. cholerae (24). Thus, in this study,
we generated a V. vulnificus mutant deficient in the epsC gene
to define the role of the T2SS in the pathogenesis of this
bacterium.
Construction and confirmation of the epsC mutant of V.
vulnificus. Deletion of the putative epsC ORF from the
genomic DNA of V. vulnificus was confirmed by PCR using the
primers epsCupF and epsCdownR (Table 2), which were spe-
cific to the upstream and downstream regions of the deleted
ORF, respectively (data not shown). To confirm that the phe-
notypes of the resultant mutant were derived from the epsC
gene knockout, a complementation plasmid containing the in-
tact epsC gene was transformed into the V. vulnificus epsC
mutant. Because the overexpressed protein band in E. coli
extracts was used to make anti-EpsC antibodies without puri-
fication, its identity was analyzed by MALDI-TOF, which
showed that it is the recombinant EpsC protein, as expected
(data not shown). Once the specificity of anti-EpsC Ab was
confirmed by Western blotting of E. coli expressing rEpsC (Fig.
1A), the cellular levels of the EpsC protein in various V. vul-
nificus strains were examined by Western blot analysis using
anti-EpsC Ab (Fig. 1B). An immunoreactive protein was pres-
ent in the extract of the wild type carrying the vector plasmid
pRK415 and the V. vulnificus epsC mutant with the comple-
mentation plasmid, but it was absent in the extract of the V.
vulnificus epsC mutant carrying pRK415.
Deletion of the epsC gene results in a dramatic defect in
secretion of various proteins from V. vulnificus. The role of the
FIG. 1. Confirmation of the deletion of epsC from V. vulnificus and
the complementation strain using anti-EspC antibodies. (A) Western
blot of extracts of E. coli BL21 carrying the expression vector pET21b
(lane 1) and pET21b pETrepsC (lane 2) with anti-EpsC Ab; (B) West-
ern blot analysis using anti-EpsC Ab on extracts of wild-type V. vulni-
ficus harboring the broad-host-range vector pRK415 (lane 1), the
epsC mutant harboring pRK415 (lane 2), and the epsC mutant
carrying pRKepsC, a complementation plasmid of the wild-type epsC
gene (lane 3).
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T2SS in the secretion of extracellular proteins was examined by
comparing the secretome profile of wild-type V. vulnificus with
that of the epsC mutant, which were harvested at the expo-
nential (OD600 	 0.8) and stationary (OD600 	 4.0) phases.
The patterns of secreted proteins from both phases were sig-
nificantly altered in the V. vulnificus epsC mutant (Fig. 2A
and B). Identification of the secreted proteins (Table 3) re-
vealed that transport proteins (a long-chain fatty acid transport
protein and an ABC-type amino acid transporter), metabolic
enzymes (UDP-sugar hydrolase and peptidyl-prolyl cis-trans
isomerase), an adhesin (N-acetylglucosamine-binding protein
A), outer membrane proteins (outer membrane protein
OmpU and a putative outer membrane protein), proteases
(elastase and chitinase), and cytolysin. All of the identified
proteins were shown to contain putative signal sequences in
their N termini. Interestingly, some exoproteins were shown to
be excreted more often from the mutant than from the wild
type, but their identities were not examined further.
To verify that the altered secretion in this mutant was due to
the deletion of the epsC gene, the mutant was complemented
with the intact epsC gene in pRK415 and its secretome was
compared with the secretomes of V. vulnificus strains contain-
ing pRK415. The wild-type and mutant cells at stationary
phase repeatedly showed similar patterns in their secretomes
(Fig. 2C). Limited identification of secreted proteins revealed
that at least three exoproteins, hemolysin, elastase, and N-
acetylglucosamine-binding protein A, were recovered to wild-
type levels when the mutant was complemented.
Comparative secretome analysis of the wild type and the
epsC mutant suggested that the T2SS was responsible for the
secretion of proteins involved in various functions of V. vulni-
ficus, including elastase (VvpE) and cytolysin (VvhA). In sub-
sequent experiments, we confirmed whether the T2SS was di-
rectly involved in the secretion of these factors of V. vulnificus.
Deletion of the epsC gene results in a dramatic defect in V.
vulnificus cytotoxicity to HEp-2 cells. Using PI staining and
FACS analysis, we asked whether a defective T2SS affected the
virulence of V. vulnificus to host cells (Fig. 3A). About 5% of
HEp-2 cells without exposure to V. vulnificus were stained with
PI, whereas 96% of HEp-2 cells exposed to exponential-phase
wild-type V. vulnificus (at an MOI of 20) were stained with PI.
When HEp-2 cells were incubated with the exponential-phase
epsC mutant, only 27% of HEp-2 cells were stained with PI
(P 	 3.46E6). Infection of HEp-2 cells with the same V.
vulnificus strains harvested at the stationary phase also resulted
in similar patterns of cytotoxicity exerted by exponential-phase
cells of V. vulnificus (data not shown). In addition, comple-
mentation of the intact espC gene into the V. vulnificus epsC
mutant increased bacterial cytotoxicity from 11% to 58% (P 	
0.017), which is almost the level of cytotoxicity shown by the
wild type carrying pRK415 (67%) (P 	 0.66).
Since the epsC gene encodes an essential component of the
T2SS, we attributed the reduced cytotoxicity of the espC
mutant to its defect in the secretion of extracellular cytotoxic
factors of V. vulnificus. Accordingly, we compared the cytotoxic
effects on HEp-2 cells by secreted bacterial proteins of various
V. vulnificus strains (Fig. 3B). The percentages of PI-stained
cells were 43 and 59% upon incubation with 4 and 8 g/ml of
secreted proteins of wild-type V. vulnificus, respectively. Cyto-
toxicity was dramatically decreased to 8.0% (P	 8.09E7) and
FIG. 2. Comparative secretome analyses of the wild-type and V.
vulnificus epsC strains. (A, B) The wild-type and epsC strains
were cultured to the exponential (OD600 	 0.8) or the stationary
(OD600 	 4.0) phase. The collected spent medium was precipitated
with equal volumes of 10% TCA and washed three times with
acetone. One hundred nanograms (OD600 	 0.8) (A) or 50 g
(OD600 	 4.0) of proteins (B) was separated by SDS-PAGE and
visualized by silver staining or Coomassie blue staining, respec-
tively. Reduced-secretion proteins in the epsC mutant were iden-
tified by trypsin treatment and subsequent MALDI/TOF or Q-TOF
analysis (Table 3). (C) Comparative secretome analysis of the wild
type carrying pRK415, the epsC mutant carrying pRK415, and the
epsC mutant carrying pRKepsC. V. vulnificus strains were cultured
to the stationary phase (OD600 	 4.0) in LBS supplemented with
tetracycline. One-hundred micrograms of proteins in each spent
medium was separated by SDS-PAGE and visualized by Coomassie
blue staining. Three representative reduced-secretion protein
bands, N-acetylglucosamine-binding protein A, hemolysin, and elas-
tase, in the epsC mutant carrying pRK415 were identified by
MALDI/TOF or Q-TOF analysis as described in Materials and
Methods.
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8.6% (P 	 1.40E4) when two concentrations of secreted pro-
teins of the epsC mutant were challenged. We then examined
whether the attenuated cytotoxicity of secreted proteins of the
epsC mutant could recover to wild-type levels by introducing
the complementation plasmid pRKepsC (Fig. 3C). With 4
g/ml of secreted proteins of the wild type carrying pRK415,
19% of the cells stained with PI, and the portion of dead cells
was increased to 95% at 8 g/ml of the same secreted proteins.
In contrast, the control strain (epsC mutant with the vector
pRK415) showed cytotoxicities of 7.4% (P 	 1.80E5) and
9.1% (P 	 1.86E6). When HEp-2 cells were incubated with
the secretome of the epsC mutant strain carrying pRKepsC,
11% of the HEp-2 cells were stained by PI with 4 g/ml of the
secretome (P 	 0.00126) and PI-stained HEp-2 cells were
increased to 74% in the presence of 8 g/ml of secreted pro-
tein (P 	 0.25).
In this experiment, the cytotoxicity of the rtxA mutant was
also measured, since RtxA is the most potent toxin of V. vul-
nificus known so far and it functions in a contact-dependent
manner (22, 28). The cytotoxicity of the rtxA mutant was
dramatically attenuated to 7.0% (Fig. 3A) (P 	 1.44E07), as
shown previously (22, 28). The V. vulnificus rtxA epsC dou-
ble mutant demonstrated a slightly lower level of cytotoxicity to
HEp-2 cells than the rtxA mutant. In contrast, the cytotoxicity
of the secretome of the rtxA mutant (95 to 98%) was higher
than that of the wild type (Fig. 3B). The secretome derived
from the epsC rtxA double mutant demonstrated a lower
level of cytotoxicity than the V. vulnificus epsC mutant (P 	
3.03E7 and 1.70E4, respectively), indicating that the mode
of cytotoxicity exerted by the epsC mutant is not caused by
RtxA, which is presumed to be secreted by the T1SS.
Deletion of the epsC gene results in a dramatic defect in
mouse lethality by V. vulnificus. We then examined the role of
the T2SS in the pathogenesis of V. vulnificus using a mouse
infection model with the wild type or epsC mutant. Mice
received an intraperitoneal injection of bacterial cells, and
their survival was monitored (Fig. 4A). All of the mice injected
with wild-type V. vulnificus were dead by 6 h postinjection,
while 8 of 10 mice injected with the epsC mutant were alive by
25 h postinjection. Therefore, the epsC mutant showed sig-
nificant attenuation in mouse lethality (P values 	 2.7E6, log
rank test).
The complemented and control V. vulnificus strains were
also tested for their virulence in a mouse model (Fig. 4B). The
epsC mutant carrying pRK415 demonstrated significantly re-
duced mouse lethality compared to the wild type carrying
pRK415 (P values 	 4.3E6, log rank test) and the epsC
mutant carrying pRKepsC (P values 	 3.9E6, log rank test).
Despite the recovered mouse lethality of the complemented
strain, it was slightly less effective than wild-type V. vulnificus
carrying pRK415, suggesting that introduction of the plasmid
containing the wild-type epsC gene into the epsC mutant
caused a partial, but significant, recovery of bacterial virulence
in mouse model experiments (P values	 0.0023, log rank test).
The T2SS is involved in the secretion of hemolysin(s) in V.
vulnificus. Based on secretome analyses, VvhA secretion was
mediated by the T2SS, and thus we examined whether EpsC
was indeed involved in the secretion of hemolysin in V. vulni-
ficus by estimating hemolytic activity and VvhA protein levels
in culture supernatants (Fig. 5). Culture media grown by var-
ious V. vulnificus strains at various growth phases were tested
for their ability to lyse human RBCs. Hemolytic activity was
maximal when the wild type carrying pRK415 entered the
stationary phase and then declined during the late stationary
phase (Fig. 5A). The level of hemolytic activity in the super-
natant from the epsC mutant carrying pRK415 was too low to
be detected in this assay, which was similar to that in the
culture supernatants of vvhA mutant V. vulnificus (Fig. 5B
and C, respectively). The V. vulnificus epsC mutant carrying
pRKepsC recovered hemolysin activity to the level of wild-type
V. vulnificus carrying the vector plasmid pRK415 (Fig. 5D).
In this hemolytic assay, the supernatant of the rtxA mutant
was also included, since V. vulnificus RtxA toxin has a hemo-
lytic activity but it functions in a contact-dependent manner
(22, 28). The hemolytic activity of the supernatant of the rtxA
mutant was similar to that of its isogenic wild type, MO6-24/O,
which was maximal at early stationary phase (Fig. 5E and F). In
the case of the V. vulnificus rtxA epsC double mutant, we
could not detect any hemolytic activities from the culture su-
pernatant at any growth phase (Fig. 5G). Therefore, VvhA
TABLE 3. Proteins of which secretion was reduced in the V. vulnificus epsC mutant
Band(s)a Methodb Protein name Molecularmass (kDa)c ORF
d Coverage (%) Score (valid score)e
1, 2 Q-TOF UDP-sugar hydrolase 62 (58) VV1_0248 5 183 (52)
3 MS Long-chain fatty acid transport protein 44 (42) VV1_1972 38 152 (81)
4 MS Outer membrane protein OmpU 37 (35) VV1_1686 30 100 (68)
5 Q-TOF ABC-type amino acid transporter 37 (34) VV1_2703 14 43 (26)
6 MS Chitinase 62 (60) VV1_0417 26 60 (56)
7 Q-TOF N-Acetylglucosamine-binding protein A 53 (50) VV2_0044 11 62 (26)
8 Q-TOF Hemolysin 53 (51) VV2_0404 77 218 (26)
9 MS Elastase 66 (63)f VV2_0974 32 152 (56)
10 Q-TOF Outer membrane protein 20 (18) VV2_0807 9 62 (27)
11 Q-TOF Peptidyl-prolyl cis-trans isomerase 20 (18)f VV1_1817 6 28 (27)
a Numbers are derived from the protein bands shown in Fig. 2.
b The identities of proteins treated with trypsin were determined by mass spectrometry (MS) or Q-TOF.
c The molecular mass of each protein before processing of the putative leader peptide, which was predicted by the SignalP 3.0 Server (http://www.cbs.dtu.dk
/services/SignalP/), is presented in parentheses (after processing).
d Protein annotation and GenBank ORF designation of V. vulnificus strain CMCP6.
e Cutoff values for validation are in parentheses.
f The predicted size of this protein is higher than the apparent size of the protein band (Fig. 2), which is presumed to be further processed.
VOL. 79, 2011 ROLE OF T2SS IN THE PATHOGENESIS OF VIBRIO VULNIFICUS 4073
activity plays a major role in the hemolytic assay using cell-free
culture supernatants.
With polyclonal Ab specific to recombinant VvhA (rVvhA),
the secretion of VvhA was specifically examined in the V.
vulnificus wild type carrying pRK415, the epsC mutant carry-
ing pRK415, the epsC mutant carrying pRKepsC, and the
vvhA mutant (Fig. 6A). The identity of the overexpressed
protein was confirmed to be VvhA by MALDI-TOF analysis
pRK415, and the epsC mutant carrying pRKepsC. Unexposed HEp-2
cells were also stained with PI as a control (CON; open bars). Error
bars represent the means  standard deviations of results from three
independent experiments. Single asterisks indicate percentages of PI-
stained cells that were significantly different (0.01 P  0.05) from
wild-type V. vulnificus cells by Student’s t test, while double asterisks
indicate a P of 0.01. P values from an ANOVA analysis are also
presented in the graph for each set of data.
FIG. 3. Role of EpsC in V. vulnificus’s cytotoxicity to HEp-2 cells.
Determination of cytotoxicities of various V. vulnificus strains (A) and
their secreted protein pools (B and C) against HEp-2 cells by pro-
pidium iodide (PI) staining. (A) Percentages of the dead HEp-2 cells
were measured after 1 h of incubation with the wild-type, epsC, rtxA,
and epsC rtxA mutant V. vulnificus strains at an MOI of 20. (B) Per-
centages of dead HEp-2 cells were measured after 4 h of incubation
with 4- or 8-g/ml protein pools secreted by the wild-type, epsC,
rtxA, and epsC rtxA mutant V. vulnificus strains. (C) Percentages of
dead HEp-2 cells were measured after treatment of secreted proteins
of the wild type carrying pRK415, the epsC mutant harboring
FIG. 4. Mouse lethality of the T2SS-defective V. vulnificus mutant.
Seven-week-old specific-pathogen-free female ICR mice were intraperi-
toneally infected with wild-type and epsC mutant V. vulnificus strains
(A). Equal numbers of bacteria (6  105) were injected into 10 mice per
group, and the survival of the mice was monitored for 25 h after injection.
Open and filled circles represent the number of live mice infected with the
wild type and epsC mutant, respectively. (B) The numbers of mice
infected with the wild type carrying pRK415, the epsC mutant carrying
pRK415, and the epsC mutant carrying pRKespC are presented as open
circles, filled circles, and open inverted triangles, respectively.
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prior to Western blot analysis (data not shown). An immuno-
reactive band of 50 kDa was detected in the culture super-
natant of the V. vulnificus wild type carrying pRK415, and it
was absent in the culture supernatants of the epsC mutant
carrying pRK415 and the vvhA mutant. As expected, the
immunoreactive band reappeared in the epsC mutant carry-
ing the complementation plasmid pRKepsC.
In the next experiment, we examined whether the secretion
FIG. 5. Hemolytic activities of secreted proteins of various V. vulnificus strains. Hemolytic activities in the culture supernatants of wild-type
MO6-24/O carrying pRK415 (A), the epsC mutant carrying pRK415 (B), the vvhA mutant (C), the epsC mutant carrying pRKepsC (D),
wild-type MO6-24/O (E), the rtxA mutant (F), and the epsC rtxA mutant (G) throughout the bacterial growth period designated by the curves
for OD600s of cultures. Serial 2-fold dilutions of supernatants were incubated with equal volumes of a 1% suspension of human RBCs for 1 h at
37°C. Hemolysin activity was expressed as a percentage (the OD540 of the sample over the OD540 of RBCs lysed by treatment with Triton X-100).
Data are presented as averages of results from three independent experiments, with error bars.
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of VvhA is mediated only by the T2SS and not by the T1SS
(Fig. 6B). Secretomes of the wild type, epsC mutant, and
tolC mutant were analyzed for the presence of VvhA, indi-
cating that secreted proteins of the tolC mutant contained
VvhA, as the wild-type secretome did. We examined the se-
cretion of RtxA, in addition to VvhA, in the culture superna-
tants of epsC and tolC mutants by Western blotting using
anti-RtxA Ab (Fig. 6C). Western blot analysis of culture su-
pernatants of V. vulnificus cells grown in the absence of the
host cells did not show any immunoreactive protein band cor-
responding to the RtxA polypeptides. However, when culture
supernatant derived from V. vulnificus cells grown in the pres-
ence of the host cell line were analyzed, several immunoreac-
tive bands were observed in the V. vulnificus wild type and
epsC mutant, which were absent in the supernatant of the
tolC mutant as well as in that of the rtxA mutant. This
suggests that RtxA is secreted via the T1SS but not via the
T2SS.
The T2SS is involved in the secretion of exoproteases in V.
vulnificus. VvpE, an elastase, was found to be a dominant
protein among the V. vulnificus secretomes, the secretion of
which was abolished by deletion of the epsC gene (Fig. 2).
Therefore, we directly examined the dependence of VvpE se-
cretion on the presence of functional EpsC. Most of all, wild-
type MO6-24/O carrying pRK415, the epsC mutant with
pRK415, and the epsC mutant with pRKepsC were evaluated
for their total extracellular protease activity by monitoring for
their ability to degrade azocasein (Fig. 7A). The culture super-
natant of the wild type carrying pRK415 efficiently degraded
azocasein. In contrast, the supernatant of the epsC mutant
carrying pRK415 demonstrated an undetectable level of azo-
casein degradation. Culture supernatants from the V. vulnificus
epsC mutant with the complementation plasmid pRKepsC
regained the ability to degrade azocasein. The supernatant of
the vvpE mutant demonstrated a low level of azocasein-de-
grading activity, but it was higher than that of the epsC mu-
tant carrying pRK415. The higher proteolytic activity of the
vvpE mutant than of the epsC mutant was also demon-
strated in the assay using a skim milk-agar plate (Fig. 7B).
Observation of the lower proteolytic activity of the epsC mu-
tant carrying pRK415 or of the epsC mutant than of the
vvpE mutant suggests the presence of an additional pro-
tease(s) secreted via the T2SS in V. vulnificus.
Using polyclonal Ab specific to recombinant rVvpE, the
secretion of elastase was specifically monitored in the culture
supernatants grown by these strains (Fig. 7C). Prior to Western
blot analysis, the recombinant protein used for immunization
was also examined by MALDI-TOF analysis, indicating that
VvpE is a recombinant elastase, as expected (data not shown).
An immunoreactive band was detected as a protein of 45 kDa
only in the supernatant of the wild type carrying pRK415 and
the epsC mutant carrying pRKepsC and not in the culture
supernatant of the epsC mutant carrying pRK415 and the
vvpE mutant of V. vulnificus. We further examined the in-
volvement of the T1SS in VvpE secretion. The activities of
VvpE in the secretomes of the wild-type, epsC, and tolC
strains were monitored by a zymographic analysis (Fig. 7D),
indicating that secreted proteins of the tolC mutant contained
VvpE activity, like the wild type (43), but that the epsC
mutant did not contain VvpE activity. It suggests that VvpE is
secreted via the T2SS but not via the T1SS.
Trapping of VvhA and VvpE in the periplasm of the V.
vulnificus epsC mutant. Since both VvhA and VvpE were not
detected in the culture supernatant of the epsC mutant, we
examined the cellular fractions containing hemolytic activity
and VvpE in the V. vulnificus epsC mutant. Specifically, we
asked if synthesized VvhA or VvpE in the cytoplasm of the
epsC mutant was not successfully secreted into the medium
through the outer membrane. Extracts of various V. vulnificus
strains, including the wild-type, epsC, and vvhA mutant V.
vulnificus strains, were divided into three fractions (cytoplas-
mic, periplasmic, and culture supernatant) and assayed for
hemolysin activity (Table 4). Hemolysin activity was present
mainly in the culture supernatant of the wild type but barely
detected in the cytoplasmic and periplasmic fractions. In con-
trast, hemolysin activity was found mainly in the periplasmic
fraction of the V. vulnificus epsC mutant, while little or no
activity was present in the cytoplasmic fraction or in the culture
FIG. 6. Secretion of hemolysins in various V. vulnificus strains. (A,
B) Secretion of VvhA hemolysin in various V. vulnificus strains.
(A) The spent media after growth by the wild type carrying pRK415
(lane 1), the vvhA mutant (lane 2), the epsC mutant carrying
pRK415 (lane 3), or the epsC mutant carrying pRKepsC (lane 4)
were analyzed by Western blot analysis using anti-VvhA Ab. (B) West-
ern blot analysis of secretomes of wild-type V. vulnificus MO6-24/O
(lane 1), the epsC mutant (lane 2), and the tolC mutant (lane 3).
(C) Secretion of RtxA in various V. vulnificus strains. Culture super-
natants were prepared from the V. vulnificus wild type (lanes 1), epsC
mutant (lanes 2), tolC mutant (lanes 3), and rtxA mutant (lanes 4)
without (left) or with (right) preincubation with human cells as de-
scribed in Materials and Methods. Concentrated supernatants were
analyzed by Western blotting using anti-RtxA Ab.
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supernatant, respectively. Hemolysin was barely detected in
any of the fractions of the V. vulnificus vvhA mutant. As a
control for preparation of the periplasmic fraction, we moni-
tored these fractions for their alkaline phosphatase activity,
which is well known to be a periplasmic enzyme. Only for
periplasmic fractions of these strains could we detect alkaline
phosphatase activity.
In the case of VvpE, the periplasmic fractions were prepared
from the wild-type, vvpE, epsC, and vvhA mutant V. vul-
nificus strains and were analyzed by Western blotting using
anti-VvpE Ab (Fig. 8). Only the periplasmic fraction of the
epsC mutant demonstrated an immunoreactive protein of 45
kDa. All these results suggest that a deficiency in EpsC func-
tion resulted in a defect of the transport of target proteins from
the periplasmic space to the outer membrane.
Differential effects of VvhA and VvpE in the cytotoxicity of V.
vulnificus. This study provides evidence that cytotoxic factors
are secreted via the T2SS in V. vulnificus. We examined the
possibility that VvhA and/or VvpE is the critical factor in
the T2SS-mediated cytotoxicity of V. vulnificus to HEp-2 cells.
The same amounts of secreted proteins of the vvhA mutant,
vvpE mutant, and its isogenic strain, the wild type, were
assayed for their cytotoxicity against HEp-2 cells by PI staining
(Fig. 9). While 59% of the HEp-2 cells treated with wild-type
V. vulnificus (P 	 0.00019) were stained with PI, 9.5% of
HEp-2 cells were stained with PI when they were treated with
the supernatant of the vvhA strain (8.0 g/ml). In contrast,
the culture supernatant of the vvpE mutant strain showed
slightly higher cytotoxicity (79%) than that of wild-type V.
vulnificus, although their difference was not statistically signif-
icant (P 	 0.28).
DISCUSSION
V. vulnificus is a Gram-negative pathogenic bacterium that
causes primary septicemia due to multiorgan failure as a result
of rapidly progressive shock syndrome (5, 12, 23). In vitro
studies using human peripheral blood mononuclear cells
(PBMC) and human Jurkat T-cell lines clearly demonstrated
that V. vulnificus can induce the death of human cells at a
dramatic rate (20, 21). In addition to the direct interaction of
live V. vulnificus with human cells (22, 27, 28, 29, 57), incuba-
tion of human cell lines with the culture supernatant of V.
vulnificus triggers the death of human cells, indicating a po-
tential role of extracellular compounds secreted from V. vul-
nificus in pathogenicity (Fig. 3B and C). We searched the
proteins secreted by the T2SS in order to better understand the
participation of bacterial secretion systems in bacterial cyto-
toxicity to human cells.
The T2SS is one of the protein secretion systems responsible
for the secretion of virulence factors in diverse Gram-negative
bacterial pathogens (7). Heat-labile enterotoxin, a main toxin
produced by enterotoxigenic E. coli, is secreted via the T2SS
(56). In Legionella pneumophila, which causes a pneumonia
known as Legionnaires’ disease, the T2SS helps the bacterium
grow and survive within various host environments, including
amoebae, macrophages, and lungs (8, 55). In this microorgan-
ism, diverse extracellular proteins are translocated via the
T2SS, including endoglucanase, aminopeptidases, a metallo-
protease, and acid phosphatases (8, 39, 45). The T2SS plays an
FIG. 7. Role of EpsC in the secretion of exoprotease(s) from V.
vulnificus. (A) Proteolytic activities in the culture supernatants ob-
tained from the V. vulnificus wild type carrying pRK415, the epsC
mutant carrying pRK415, the epsC mutant carrying pRKepsC, and
the vvpE mutant. The total proteolytic activity was assayed after a 1-h
incubation of the cell-free supernatant with an equal volume of azo-
casein. Upon termination of the reaction, the level of the produced
azopeptide was determined by OD442 determination. (B) Comparison
of the total protease activity shown by V. vulnificus strains, namely, the
wild type (spot 1), epsC mutant (spot 2), and vvpE mutant (spot 3).
V. vulnificus cells were spotted on a 1.5% skim milk-agar plate, and the
cleared zones around bacterial colonies were monitored after 16 h of
incubation at 30°C. (C) Secretion of VvpE in various V. vulnificus
strains. The spent media after growth by the wild type carrying pRK415
(lane 1), the vvpE mutant (lane 2), the epsC mutant carrying
pRK415 (lane 3), and the epsC mutant carrying the complementation
plasmid pRKepsC (lane 4) were analyzed by Western blotting using
anti-VvpE Ab. Numbers at the left of the gel are molecular masses (in
kilodaltons). (D) Zymographic analysis of VvpE activity. Cell-free
supernatants of wild-type V. vulnificus MO6-24/O (lane 1), the tolC
mutant (lane 2), and the epsC mutant (lane 3) collected at the
stationary phase (OD600 of 4.0) were loaded on a 12% polyacryl-
amide gel copolymerized with 0.3% gelatin. In-gel proteolytic activities
were visualized as clear zones in a gelatin-containing gel upon Coo-
massie brilliant blue R staining. A clear zone produced by the elastase
(VvpE) is indicated with an arrow.
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important role in the pathogenesis of V. cholerae by secreting
cholera toxin (48), which is responsible for the symptoms of the
disease (17). The role of the T2SS in V. vulnificus, however, has
been studied by using a pilD mutant strain defective in both the
T2SS and type IV pili (36, 37). Therefore, in the present study,
we investigated the roles of the T2SS in V. vulnificus by using
a mutant defective in epsC, encoding an essential structural
component of the T2SS, and found that its T2SS is involved in
the secretion of diverse exoproteins (Fig. 2 and Table 3), in-
cluding known secreted factors such as VvhA and VvpE (Fig.
5 to 7), and that its deletion results in a significant attenuation
in mouse lethality (Fig. 4).
VvhA is a representative exotoxin produced by V. vulnificus
(41). Although the cytotoxic mechanism of purified VvhA has
been extensively studied in various cell lines (26, 30, 51, 63),
the pathological significance of VvhA remains controversial.
Depletion of VvhA in V. vulnificus through a deletion of the
vvhA gene resulted in the same 50% lethal dose (LD50) as that
of the wild-type strain in mice mortality assays (60). However,
an intraperitoneal injection of the vvhA mutant resulted in a
3-fold-increased LD50, and an oral inoculation of the vvhA
mutant further increased its LD50 value by 5-fold compared to
that of the wild type (9). In addition to the effects of bacterial
cells on mice, the cytotoxic effects of the secreted protein pools
from each bacterial strain have been studied by estimating the
lactate dehydrogenase (LDH) release from and observing the
morphological change of human cell lines, showing contradic-
tory results. Secreted proteins prepared from the vvhA mu-
tant showed decreased cytotoxicity against CHO cells when
they were scored by microscopic observation (60). On the
other hand, treatment of HEp-2 cells with the vvhA secre-
tome resulted in a release of LDH equal to that with the
wild-type secretome (9). In our study, the cytotoxicity of the
vvhA secretome was measured by PI staining and subsequent
FACS analysis of treated HEp-2 cells (Fig. 9), which clearly
indicated that the mutant secretome shows significantly atten-
uated cytotoxicity.
The V. vulnificus epsC mutant showed reduced exoprotease
activity (Fig. 7A and B), in which the mainly reduced exopro-
tease was identified as VvpE (Fig. 7C and D). VvpE is an
exoprotease responsible for the pathology caused by V. vulni-
ficus, which was confirmed by using a purified enzyme (25, 34).
However, deletion of vvpE in V. vulnificus does not alter the
cytotoxicity against INT407 cells (13) or HEp-2 cells (9). In a
mouse model, the vvpE mutant demonstrated a lower LD50 if
the mutant cells were administrated via the oral route (9, 49),
but it showed an LD50 similar to that of the wild type if the
bacteria were injected via an intraperitoneal route (9, 13, 49).
A cytotoxicity assay using the secreted proteins of the vvpE
mutant demonstrated higher LDH release from HEp-2 cells
TABLE 4. Localization of hemolytic and alkaline phosphatase activities in fractions of various V. vulnificus strains
Strain
Hemolytic activity (U/ng protein) in indicated cell fractiona Alkaline phosphatase activity in indicated cell fractionc
Cytoplasm Periplasm Supernatant Cytoplasm Periplasm Supernatant
Wild type NDb ND 1,640 ND 74 ND
epsC mutant 0.735 118 ND ND 48 ND
vvhA mutant ND ND ND ND 43 ND
a Hemolytic activity was calculated by Shinoda et al. (51).
b ND, not detectable (0.5 U/ng protein).
c Alkaline phosphatase activity was calculated by Yim and Villarejo as (OD420/reaction time in minutes  milligrams of protein)  1,000 (62).
FIG. 8. Western blot analysis of periplasmic fractions using anti-
VvpE Ab. The bacterial cells of the wild type (lane 1), the vvpE
mutant (lane 2), the epsC mutant (lane 3), and the vvhA mutant
(lane 4) were grown to an OD600 of 1.0, and then each periplasm
fraction was prepared as described in Materials and Methods. The
resultant periplasmic fractions were analyzed by Western blot analysis
using anti-VvpE Ab. The number at the left of the gel is the molecular
mass (in kilodaltons).
FIG. 9. Differential roles of VvhA and VvpE in cytotoxicity to
HEp-2 cells. HEp-2 cells were treated with 8 g/ml of secreted pro-
teins prepared from V. vulnificus MO6-24/O, the vvhA mutant, or the
vvpE mutant and then incubated for 4 h. Percentages of dead HEp-2
cells were determined by PI staining and subsequent FACS analysis.
HEp-2 cells unexposed to the secreted proteins of V. vulnificus were
also stained with PI (open bar). Error bars represent the means 
standard deviations of results from three independent experiments.
Double asterisks indicate that percentages of PI-stained cells were
significantly different (P  0.01) from that of wild-type V. vulnificus
PI-stained cells by Student’s t test. P values of ANOVA analysis are
also presented in the graph.
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than in the wild type (9), which is in accordance with our
observation determined by PI staining and the FACS method
(Fig. 9). Therefore, VvhA is a direct cytotoxic factor, whereas
VvpE may function indirectly to modulate other cytotoxic fac-
tors in a negative mode. The higher cytotoxicity of the vvpE
strain has been attributed to the increased level of VvhA in the
vvpE mutant, raising the possibility that VvhA is one of the
target proteins inactivated by VvpE (48; H.-J. Lee, M.-A. Lee,
and K.-H. Lee, unpublished result). Thus, the differential con-
tributions of VvhA and VvpE and their interactive character-
istics in the pathogenesis of V. vulnificus need further investi-
gation.
The V. vulnificus epsC mutant showed no apparent hemo-
lytic activity (Fig. 5) and an absence of VvhA in its secreted
protein pool (Fig. 6A). Thus, no apparent hemolytic activity in
the epsC culture supernatant was assumed to be caused
mainly by its defects in the secretion of VvhA. Through ana-
lyses of cellular localization of VvhA among the separated
fractions of the mutant, we showed hemolytic activity en-
trapped in the periplasmic space of this mutant (Table 4).
These results indicate that translocation of VvhA from the
periplasm to outside the cell is required for EpsC to be func-
tional and that its transport from the cytoplasm to the periplas-
mic space is independent of EpsC but may occur via the Tat or
Sec secretion system.
We also examined the role of RtxA, since it is also involved
in the hemolytic function shown by V. vulnificus (22). The V.
vulnificus rtxA mutant was dramatically defective in cytotox-
icity against HEp-2 cells (Fig. 3A), whereas its culture super-
natant was still proficient in killing HEp-2 cells with a higher
degree of cytotoxicity than the wild type by a yet-unknown
mechanism (Fig. 3B). These results indicate that V. vulnificus
needs to directly contact host cells to exhibit the extracellular
function of RtxA, as previously shown (22, 28). In addition,
RtxA secretion was not mediated by the T2SS but rather hap-
pened through the T1SS, as shown in the experiment using the
V. vulnificus tolC mutant (Fig. 6C). Thus, the defect in he-
molytic activity and the reduced virulence of the epsC mutant
were not derived from altered secretion of RtxA.
We extended the list of proteins secreted by the T2SS, in
addition to VvhA and VvpE, in V. vulnificus through compar-
ative secretome analysis between the wild type and the epsC
mutant (Fig. 2). All the identified proteins, whose secretion
was abolished or highly reduced in the T2SS-defective mutant,
were shown to have the leader peptide sequences (10), as
predicted by the SignalP 3.0 server (http://www.cbs.dtu.dk
/services/SignalP/). It strongly suggests that the identified
proteins in this study are targets for the V. vulnificus T2SS
(Table 3).
Several putative membrane-bound proteins were found to
be secreted at basal levels in the T2SS-defective strain. In V.
cholerae, loss of extracellular secretion due to a T2SS defect
results in a broad range of alterations in its outer membrane
integrity, which causes interference in its barrier function and
induction of the extracytoplasmic stress sigma factor RpoE
(53). Cell envelope perturbation due to a T2SS defect induces
oxidative stress and misregulation of iron homeostasis in V.
cholerae (52). In Shewanella oneidensis, the T2SS is also in-
volved in the extracellular secretion of two outer membrane
lipoproteins, MtrC and OmcA, which are important for reduc-
ing metal oxide (50). We observed that the loss of T2SS func-
tion resulted in the increased sensitivity of V. vulnificus to bile
salt (data not shown), indicating that the outer membrane
integrity was altered by the loss of the T2SS in V. vulnificus.
Therefore, the specific role of the T2SS in stress responses of
V. vulnificus under host environments will be another interest-
ing aspect to be investigated.
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